CAR-T therapy approved for non-Hodgkin's lymphoma

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2017年 / 13卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2752 / 2752
页数：1
相关论文
共 50 条
  • [31] Lines of Therapy Before Autologous Stem Cell Transplant and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 6 - 7
  • [32] Metabolic Kinetics of Non-Hodgkin Lymphoma Prior to CAR-T Infusion: Prognostic Factors and Risk Stratification
    Breen, W.
    Hathcock, M.
    Young, J. R.
    Stish, B. J.
    Kowalchuk, R. O.
    Bansal, R.
    Khurana, A.
    Bennani, N.
    Paludo, J.
    Bisneto, J. Villasboas
    Wang, Y.
    Ansell, S. M.
    Peterson, J. L.
    Johnston, P.
    Lin, Y.
    Lester, S. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S131 - S132
  • [33] Rituximab for the therapy of non-Hodgkin's lymphoma
    Rummel, M. J.
    ONKOLOGE, 2007, 13 (03): : 227 - +
  • [34] Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)
    Khurana, Arushi
    Hathcock, Matthew A.
    Habermann, Thomas M.
    Al Saleh, Abdullah S.
    Gandhi, Sangeetha
    Truong, Tuan A.
    Bennani, Nabila
    Paludo, Jonas
    Villasboas, Jose C.
    Ansell, Stephen M.
    Inwards, David J.
    Porrata, Luis F.
    Johnston, Patrick B.
    Micallef, Ivana
    Lin, Yi
    BLOOD, 2020, 136
  • [35] Antibody therapy for non-Hodgkin's lymphoma
    Ansell, SM
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (02) : 175 - 181
  • [36] CAR-T Cells Directed Against B Cell Surface Antigens for the Targeting of B Cell Non-Hodgkin's Lymphoma
    Bunse, Mario
    Pfeilschifter, Janina
    Bluhm, Julia
    Uckert, Wolfgang
    Westermann, Joerg
    Rehm, Armin
    Zschurnmel, Maria
    Hoepken, Uta
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 39 - 39
  • [37] Effect of Radiation Therapy on Outcomes after CAR T-Cell Therapy for Non-Hodgkin Lymphoma
    Kapoor, N.
    Mo, X.
    Sigmund, A.
    Saad, A.
    Bajwa, A.
    Voorhees, T.
    Kittai, A.
    de Lima, M.
    Jaglowski, S.
    Denlinger, N.
    Welliver, M. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E354 - E354
  • [38] Cytopenia after CAR-T cell therapy: Analysis of 63 patients with relapsed and refractory B-cell non-Hodgkin lymphoma
    Qiu, Tingting
    Hu, Luan
    Zhang, Yongtian
    Wang, Ying
    Ma, Sha
    Li, Depeng
    Li, Zhenyu
    Xu, Kailin
    ONCOLOGY LETTERS, 2023, 26 (02)
  • [39] Glycolytic activity following anti-CD19 CAR-T cell infusion in non-Hodgkin lymphoma
    Vallet, Nicolas
    Larochelle, Laurianne Drieu
    Santiago-Ribeiro, Maria-Joao
    Villate, Alban
    Eloit, Martin
    Ciree, Arnaud
    Zaragoza, Laura
    Andre, Virginie
    Prat-Lepesant, Marie
    Herault, Olivier
    Arbion, Flavie
    Blasco, Helene
    Gyan, Emmanuel
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2025, 55 (02)
  • [40] Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL)
    Habib, Alma
    Welkie, Rina
    Butman, Jacob
    Silberman, Pedro C.
    Forero, Jose Vicente
    Sawalha, Yazeed
    Christian, Beth
    Maddocks, Kami J.
    Epperla, Narendranath
    Jaglowski, Samantha Mary
    Bond, David Alan
    Choe, Hannah Kyung
    Brammer, Jonathan Edward
    Kittai, Adam
    Bezerra, Evandro
    Voorhees, Timothy
    Vasu, Sumithira
    Wall, Sarah Allison
    De Lima, Marcos J. G.
    Denlinger, Nathan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345